High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT

This study has suspended participant recruitment.
(A leukaemia case was reported in patient treated with a similar vector. For safety risk we stopped recruitment)
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
First received: March 9, 2009
Last updated: May 12, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)